News for Vertex Pharmaceuticals Incorporated - Google FinanceNews for Vertex Pharmaceuticals Incorporated - Google FinanceVertex Pharmaceuticals Announces Proposed Public Offering of Common Stock- September 17, 2008 Vertex Pharmaceuticals Announces Proposed Public Offering of Common Stock MarketWatch - 2 hours ago , , ) today announced that it intends to offer , subject to market and other conditions , 7,000,000 shares of its common stock in an underwritten public offering under an automatically effective ...http://www.marketwatch.com/news/story/vertex-pharmaceuticals-announces-proposed-public/sto... Analyst Blog Vertex Pharma's Ebb & Flow- September 17, 2008 Analyst Blog Vertex Pharma's Ebb & Flow Zacks.com - 3 hours ago Vertex Pharmaceuticals , Inc . ( VRTX ) represents an attractive long - term opportunity based on the potential blockbuster sales of telaprevir.Other pipeline candidates such as VX - 702 , VX ...http://www.zacks.com/stock/news/14768/Vertex+Pharma's+Ebb+&%3B+Flow Alnylam Adds Another RNA Approach, Vertex Tackles Hardest Hep C Cases, Zafgen Places Big Bet on Fat Shrinkers, & More Life Sciences News- September 10, 2008 Alnylam Adds Another RNA Approach, Vertex Tackles Hardest Hep C Cases, Zafgen Places Big Bet on Fat Shrinkers, & More Life Sciences News Xconomy - Sep 10, 2008 New England life sciences firms have been making some fascinating strategic moves recently , and a lot of our coverage this last week was focused on understanding these new strategies.- Alnylam ...http://www.xconomy.com/boston/2008/09/10/alnylam-adds-another-rna-approach-vertex-tackles-... FirstAlert: 3-3:55 PM Investrend Bestcalls- September 9, 2008 FirstAlert: 3-3:55 PM Investrend Bestcalls Trading Markets (press release) - Sep 9, 2008 ( financialwire . net via COMTEX ) - - WMGI Quote Chart News PowerRating - - September 9 , 2008 ( Financial Wire ) Conference calls scheduled at 3 to 3 : 55 pm on Investrend Broadcast ...http://www.tradingmarkets.com/.site/news/Stock%20News/1869524/ Vertex Fending Off Competitors By Treating the Toughest Patients With Hepatitis C- September 9, 2008 Vertex Fending Off Competitors By Treating the Toughest Patients With Hepatitis C Xconomy - Sep 9, 2008 Vertex Pharmaceuticals is being chased by a couple of deep - pocketed competitors - Schering - Plough and Roche - in the race to develop the next big thing for patients with the hepatitis C virus.Now ...http://www.xconomy.com/boston/2008/09/09/vertex-fending-off-competitors-by-treating-the-to... Vertex Pharmaceuticals Announces Webcast of its Presentation at Two Investor Conferences- September 5, 2008 Vertex Pharmaceuticals Announces Webcast of its Presentation at Two Investor Conferences PharmaLive.com (press release) - Sep 5, 2008 CAMBRIDGE , Mass . - - ( BUSINESS WIRE ) - - Sep 4 , 2008 - Vertex Pharmaceuticals Incorporated ( Nasdaq : VRTX ) today announced that it will webcast its corporate presentation at the 3rd Annual ...http://www.pharmalive.com/News/index.cfm?articleid=568875&categoryid=62 Vertex Pharmaceuticals Announces Webcast of its Presentation at Two Investor Conferences- September 4, 2008 Vertex Pharmaceuticals Announces Webcast of its Presentation at Two Investor Conferences MarketWatch - Sep 4, 2008 , , ) today announced that it will webcast its corporate presentation at the 3rd Annual Citi Biotech Day on Monday , September 8 , 2008 at 1 : 50 pm EDT and at the Morgan Stanley Global Healthcare ...http://www.marketwatch.com/news/story/vertex-pharmaceuticals-announces-webcast-its/story.a... Ahead of the Bell: Vertex downgraded- September 3, 2008 Ahead of the Bell: Vertex downgraded Forbes - Sep 3, 2008 AP 09.03 . 08 , 9 : 27 AM ETAn Oppenheimer analyst downgraded Vertex Pharmaceuticals Inc . Wednesday , saying the stock should trade around its current levels because the company won ' t have ...http://www.forbes.com/feeds/ap/2008/09/03/ap5383307.html |